Pfizer Reaches $93m Deal On Decade-Old Lipitor Antitrust Suit
Claims From 2012 Suit Included ‘Pay-For-Delay’ Deal With Ranbaxy
Executive Summary
An antitrust lawsuit accusing Pfizer of conspiring to delay generic competition to its Lipitor blockbuster came soon after generics entered the US market in November 2011. Only now, after a decade of back and forth, has a deal been agreed to dismiss the accusations.